IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q2 2018 Holdings

Filed 2018-08-13 | 9 holdings | $17.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc.(ADMA)COM000899104$16.3M3,608,17195.6%
Loxo Oncology Inc.COM548862101$596.6K3,438,9203.5%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$60.2K2,240,0000.4%
Viewray Inc.(VRAYQ)COM92672L107$51.8K7,480,8870.3%
Transenterix Inc.COM NEW89366M201$27.9K6,389,3520.2%
Cidara Therapeutics Inc.COM171757107$5.3K1,021,1480.0%
Chimerix Inc.(CMRXEUR)COM16934W106$2.3K472,9430.0%
Pernix Therapeutics Hldgs Inc.DEBT 4.250% 4/071426VAK4$1.1K$2,500,0000.0%
Pernix Therapeutics Hldgs Inc.COM NEW71426V306$510210,0000.0%